Showing 67,621 - 67,640 results of 108,424 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (nn decrease)) ))', query time: 1.63s Refine Results
  1. 67621

    Selective Enrichment of Cysteine-Containing Phosphopeptides for Subphosphoproteome Analysis by Mingming Dong (1471396)

    Published 2015
    “…Interestingly, amino acid residues surrounding the identified phosphosites were enriched with buried residues (L, V, A, C) while depleted with exposed residues (D, E, R, K). …”
  2. 67622

    Image_1_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  3. 67623

    DataSheet_1_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.docx by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  4. 67624

    Viral replicative advantages and pathological consequences related to STAT3-altered function. by Armando Andres Roca Suarez (4967134)

    Published 2018
    “…ANGPTL4, angiopoietin-like protein 4; APR, acute phase response; BIRC5, baculoviral IAP repeat-containing protein 5; CCL5, C-C motif chemokine ligand 5; DCs, dendritic cells; DC-SIGN, dendritic cell-specific ICAM-3-grabbing non-integrin 1; EBV, Epstein–Barr virus; FOS, proto-oncogene c-Fos; HCC, hepatocellular carcinoma; HCMV, human cytomegalovirus; HCV, hepatitis C virus; HEV, hepatitis E virus; HSCs, hepatic stellate cells; IAV, influenza A virus; IDO1, indoleamine 2,3-dioxygenase 1; IL-10, interleukin 10; ISG, interferon-stimulated gene; JUN, proto-oncogene c-Jun; KSHV, Kaposi’s sarcoma-associated herpesvirus; MCL1, induced myeloid leukemia cell differentiation protein Mcl-1; MDSCs, myeloid-derived suppressor cells; MT, microtubule; MUC1, mucin 1 cell surface associated; MuV, mumps virus; NPC, nasopharyngeal carcinoma; NR4A2, nuclear receptor subfamily 4 group A member 2; PCBP2, poly(rC)-binding protein 2; PD-L1, programmed cell death 1 ligand 1; RTA, R transactivator; RVFV, Rift Valley fever virus; STAT3, signal transducer and activator of transcription 3; TGF-β, transforming growth factor beta; T<sub>reg</sub>, regulatory CD4<sup>+</sup> T cell; VZV, varicella-zoster virus.…”
  5. 67625

    Image_3_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  6. 67626

    Image_4_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  7. 67627

    Image_2_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  8. 67628

    Week 6 & 7 Experimental Design: Impact of the Anthropocene on bug abundance by Naduni Kurukulasooriya (795949)

    Published 2015
    “…Every 5 meters was considered a new group, the first 5 meters was Group 1 and the last was Group 6. …”
  9. 67629
  10. 67630
  11. 67631

    Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  12. 67632

    Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  13. 67633

    Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  14. 67634

    Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  15. 67635

    Temporal Trend in Young-Onset Type 2 Diabetes - the Macrovascular and Mortality Risk: Study of UK Primary Care Electronic Medical Records by Digsu N. Koye (8881108)

    Published 2020
    “…The incidence rates of ASCVD and ACM declined in people aged ≥50 years, but did not decrease in people <50 years. Compared to people aged ≥50 years, those aged 18-39 years at diagnosis had higher obesity (71% obese), higher HbA1c (8.6%), 71% had high LDL-C, while only 18% were on cardio-protective therapy. …”
  16. 67636

    Plasma membrane vesicles (ROV) of cancer cells can produce ATP and PP<sub>i</sub> with acid gradient. by Gautam Dhar (723875)

    Published 2015
    “…Lane 1, untreated sample; lane 2, phosphatase (P-ase): PP<sub>i</sub> band decreased; lane 3, pyrophosphatase (PP<sub>i</sub>-ase): PP<sub>i</sub> band decreased; lane 4, nicotinamide mononucleotide adenylyl transferase 1 (NMNAT1) and excess NAD: PP<sub>i</sub> band decreased and ATP band appeared; lane 5, untreated sample; lane 6, ATP sulphurylase and excess Adenosine-5’- phosphosulphate (APS): PP<sub>i</sub> band decreased and ATP band appeared. …”
  17. 67637

    Kinetics of T3 target genes expression in wild-type and <i>TRα<sup>AMI</sup>/S</i> mice in the cerebellum as measured by Q-RT-PCR. by Fabrice Chatonnet (37037)

    Published 2012
    “…<p>Expression levels were calculated for each target gene by Q-RT-PCR in wild-type and <i>TRα<sup>AMI</sup>/S</i> littermates at P4, P8, P15 and P21 (minimum 3 animals of each genotype for each time point). Data are expressed as mean ± SD using wild-type P4 values (A), for genes with decreasing or stable expression levels over time or P21 (B), for genes with increasing expression levels, as a reference for each genotype. …”
  18. 67638

    Zerumbone induced caspase activation subsequent to mitochondrial transmembrane potential loss. by Praveen K. Sobhan (220116)

    Published 2013
    “…Imaging for Hoechst, TMRM, ECFP, and EYFP FRET were carried out using a 96 well plate Bio-imager as described at the indicated time points. …”
  19. 67639

    Cellular characteristics of <i>M</i>. <i>commoda</i> during short-exposure light shift experiments and qPCR analysis of three genes. by Marie L. Cuvelier (3825829)

    Published 2017
    “…Values >1 increased relative to the T<sub>0</sub> control, while those <1 decreased. Note differences in y-axis scales. Samples that were significantly different (<i>p</i><0.01) from the control (*) and HL+UV samples that were significantly different from HL at the same time point (^) are denoted. …”
  20. 67640

    Cold pressor, 4 group. by Paul M. Macey (316393)

    Published 2014
    “…For females (<b>B</b>) and males (<b>C</b>), changes in BOLD signals relative to baseline (group mean ± SE), with time-points of significant increase or decrease relative to baseline within-group, and time-points of between-group differences (RMANOVA, <i>p</i><0.05).…”